维普中文期刊产品整合服务
42篇 您的检索式:作者名="Brixen"
    题名 作者 年代 出处 被引量
1New markers of bone metabolism:clinical use in metabolic bone disease显示文摘Eriksen EF Brixen K Charles P 1995Euro J Endocrinol1995,132,:1
2Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphataes and serum bone Gla-protein显示文摘 Nielsen H K Eriksen E F 1989Calcif Tissue Int1989,44,:1
3Fracture Risk Prediction Using Phalangeal Bone Mineral Density or FRAX-A Danish Cohort Study on Men and Women 显示文摘Friis-Holmberg T Rubin KH Brixen K 2014Clin Densitom2014,17,1:1
4Changes in biochemical markers of osteoblastic activity during the menstrual cycle显示文摘Nielsen HK Brixen K Bouillon R 1990J Clin Endocrinol Metab1990,70,5:1
5Inci- dence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer 显示文摘AItaf R Lund Brixen A Kristensen B 2014Oncology2014,87,3:1
6Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study显示文摘Brixen K Kassem M Nielsen HK 1995J Bone Miner Res1995,10,:1
7Teriparatide (biosynthetic human parathyroid hormone 1-34):a new paradigm in the treatment of osteoporosis显示文摘BRIXEN K T CHRISTENSEN B EJERSTED C 2004Basic Clin Phannacol Toxicol2004,94,6:1
8Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-NTX are predictive for early progression of the bone disease during standard chemotherapy 显示文摘Abildgaard N Brixen K Kristensen JE 2003Br J Haematol2003,120,:1
9Polymorphisms in the vitamin D receptor gene and bone mass,bone turnover and osteoporotic fractures 显示文摘Langdahl BL Gravholt CH Brixen K 2000Eur J Clin Invest2000,30,7:1
10Changes in biochemical markers of osteoblastic activity during the menstrual cycle显示文摘Nielsen HK Brixen K Bouillon R 1990J Clin Endocrinol Metab1990,70,5:1
11Differing effects of PTH 1–34, PTH 1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18‐month open‐labeled observational study using HR‐pQCT显示文摘Stinus Hansen Ellen M Hauge Jens‐Erik Beck Jensen Kim Brixen 2013J Bone Miner Res2013,,4:1
12New markers of bone metabolism:clinical use in metablic bone disease显示文摘ERIKSEN EF BRIXEN K CHARLES P 1995Euro J Endocrinol1995,132,:1
13Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosa显示文摘STOVING RK ANDRIES A BRIXEN K 2009J Psychiatr Res2009,43,7:1
14Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets 显示文摘Beck-Nielsen SS Brixen K Gram J 2012J Hum Genet2012,57,7:1
15Fracture Risk in Perimenopausal Women Treated with Beta-Blockers显示文摘Lars Rejnmark Peter Vestergaard Moustapha Kassem Bo Rud Christoffersen Niels Kolthoff Kim Brixen Leif Mosekilde 2004Calcified Tissue International2004,,5:1
16A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers显示文摘Brixen K Nielsen HK Mosekilde L 1990J Bone Miner Res1990,5,6:1
17Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone dis- ease during standard chemotherapy 显示文摘ABILDGAARD N BRIXEN K KRISTENSEN JE 2003Br J Haematol2003,120,2:1
18New markers of bone metabolism:clinical use in metabolic disease显示文摘Eriksen EF Brixen K Charles P Eur J Endocrinol0,132,:1
19New markers of bone metabolism,clinical use in metabolic bone disease显示文摘Eriksen EF Brixen K Charles P 1995Euro J Endocri-nol1995,132,:1
20New markers of bone metabolism:clinical use in metabolic disease显示文摘 Brixen K Charles P 1995Eur J Endocrinol1995,132,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费